Skip to content
Screener

Protagonist Therapeutics PTGX Segment Reporting, Other Segment Item, Amount

Segment Reporting, Other Segment Item, Amount at other companies

ConocoPhillips logo
ConocoPhillipsCOP
$7.45B+42.3%
PRA Group logo
PRA GroupPRAA
$35.48M-6.5%
Matthews International logo
Matthews InternationalMATW
-$15.63M-883%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$25.48M+4,316%
Radiant Logistics logo
Radiant LogisticsRLGT
-$271K-113%
Microbot Medical logo
Microbot MedicalMBOT
$557K+7.3%

Segments

By segment

See full
Single Reportable$81K+325%

Other financials

Income statement

See full
Revenue$213.5M+3,749%
Operating income$158.8M+478%
Net income$162.8M+568%
EPS (diluted)$2.29+516%

Balance sheet

See full
Cash & equivalents$420.1M+149%
Total debt$9.2M-18.3%
Total equity$841.5M+26.0%
Total assets$885.5M+23.3%

Cash flow

See full
Operating cash flow$219.1M—
CapEx$168.0K-79.3%
Free cash flow$218.9M—

Valuation

See full
Market cap$8.83B+165%
Enterprise value$8.42B+165%
P/E106.5×+42.4×
P/S31.3×+15.4×

Profitability

See full
Operating margin20.7%+9.2pp
Net margin29.4%+4.5pp
FCF margin-12,264.3%-12,527pp

Returns & leverage

See full
Return on equity11%+2.4pp
Debt / equity0×0.0×
Current ratio21.7×+4.7×